More Confusion on Sovaldi and Government Granted Monopolies at the Washington Post

Sometimes it seems like we are living in the Bizarro World when it comes to talking about drug prices. This is one of those times.

The Washington Post's Wonkblog had a Q& A on Sovaldi, the new drug for Hepatitis C that is being sold for $84,000 in the United States. In the final answer about the price of the drug the piece tells readers:

"Sovaldi is cheaper in countries where the government sets drug prices, ranging from $900 in Egypt to $66,000 in Germany."

This is almost the opposite of...